Trial Profile

A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Folitixorin (Primary) ; Methotrexate
Indications Folic acid deficiency; Osteosarcoma
Focus Therapeutic Use
Acronyms FORTO
Sponsors Isofol Medical

Most Recent Events

02 Sep 2016 Status changed from recruiting to completed.
24 Aug 2015 Planned End Date changed from 1 May 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.
24 Aug 2015 Planned primary completion date changed from 1 May 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com